Eighteen months into the pandemic, states continue to report flawed racial and ethnic data on vaccine administration; promising study results have been seen for a breast cancer pill; 2 billion COVID-19 vaccines have been administered worldwide.
With states being left to equitably distribute vaccines to their vulnerable citizens throughout the COVID-19 pandemic, gaps and inconsistencies in data have made these efforts difficult to track, Kaiser Health News reports. Inconsistent data could be leaving out Black and Latino communities when it comes to administering vaccines. A lack of uniform standards for every state compounds this challenge, and rates reported in states like Missouri illustrate how these gaps have led to real-world consequences. Since February, state officials in Missouri have acknowledged their data are wrong but have not managed to fix it or offer any explanations as to why.
Early initial treatment findings show that Lynparza (olaparib) helps keep certain early-stage, triple-negative breast cancers at bay, according to The Associated Press. Findings were published in The New England Journal of Medicine and revealed the pill can help patients with breast cancer with harmful mutations live longer without disease. However, patients had to have been treated with standard surgery and chemotherapy. All 1836 patients included in the study had BRCA1 and BRCA2 mutations that can predispose individuals to breast cancer. After 3 years, 86% of those who received treatment were alive without a cancer recurrence compared with 77% in the placebo group.
Two billion COVID-19 vaccines throughout the world have now been administered, Bloomberg reports. The milestone comes after the United States announced it has lost over 600,000 individuals to COVID-19 and hundreds of deaths continue to be reported each day. However, the 2 billion mark comes around 6 months after the first vaccines were administered and estimates predict it will take another 9 months to vaccinate 75% of the world’s population. Globally, around 3.7 million individuals have died from COVID-19 in the past 18 months. The vaccine rollout has also been largely uneven with wealthier countries administering shots at much faster paces.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More